Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Tuesday, December 29, 2015
PixarBio Corporation announced today the appointment of Steven Chartier as V.P. of Regulatory Affairs.
read more
Friday, December 22, 2017
PixarBio developers of NeuroRelease NR14 announce an agreement between PSI, a Lubrizol Corporation Company, to cGMP manufacture PixarBio’s NR14.
read more
Tuesday, January 29, 2019
Pivot announced the company has entered into a contract manufacturing agreement with Growpacker to produce Pivot's topical gels, creams and beverages for the California cannabis market.
read more
The Pistoia Alliance, a global, not-for-profit alliance that advocates for greater collaboration in life sciences R&D, is launching two complementary initiatives to transform pharmacovigilance (PV) in response to growing member demand.
read more
Tuesday, October 27, 2026
Piramal Pharma Solutions’ Pithampur manufacturing site in India has won the company’s annual Excellence in Patient Centricity Award for a digital dashboard connecting production and supply data with estimates of patient reach.
read more
Wednesday, September 30, 2026
Piramal Pharma Solutions and nonprofit generic drug manufacturer NP2 expect to complete the development phase of their injectable cyclophosphamide product in October. Development is taking place at Piramal’s sterile injectable facility in Lexington, ...
read more
Piramal Pharma Solutions (PPS) announced that its Grangemouth, UK facility has completed production of its 1,500th antibody-drug conjugate (ADC) batch. The milestone batch represents a commercial oncology product.
read more
Thursday, September 19, 2024
Piramal Pharma Limited embarked on its sustainability journey as the Science Based Targets initiative (SBTi) officially validated the company’s near-term greenhouse gas (GHG) emission reduction targets.
read more
Piramal Pharma announced the company will be partnering with Epirium Bio on a manufacturing relationship for new orphan drugs.
read more
Tuesday, December 21, 2021
Piramal Pharma Limited (PPL) announced an investment of INR101.77cr in Yapan Bio Pvt Ltd (“Yapan”) of Hyderabad, India, augmenting the capabilities of its Contract Development and Manufacturing Organization (CDMO) business, Piramal Pharma Solutions (...
read more
Wednesday, August 19, 2026
Piramal Pharma Ltd. has completed the acquisition of an additional 40.67% stake in Hyderabad-based biologics contract development and manufacturing organization Yapan Bio Private Ltd., raising its ownership to 74% and making the company a Piramal ...
read more
Wednesday, March 29, 2023
Piramal Pharma Solutions announced that the company has completed the successful integrated development and manufacturing of drug substance and drug product for Brenzavvy™ (bexagliflozin), TheracosBio’s recently approved treatment for type 2 diabetes...
read more
Piramal Pharma said it began FY27 with stronger revenue and margin expansion, driven by broad-based growth across its contract development and manufacturing, complex hospital generics and consumer healthcare businesses.
read more
PPL's, Piramal Pharma Solutions, announced the Company has entered into a Master Services Agreement.
read more
Wednesday, November 19, 2025
Piramal Pharma Solutions announced that its Grangemouth, UK facility has received updated MHRA GMP certificates following a successful compliance report and desktop inspection.
read more